Monster Energy ITC investigation impacts grey-market imports, setting CPG precedent
The US ITC has launched an investigation into Monster Energy's claims of trademark infringement by unauthorised 'grey-market' imports, which could redefine brand protection strategies for CPGs.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Washington D.C., United States — 13 July 2026
The US International Trade Commission (ITC) has initiated an investigation into alleged trademark infringement by 'grey-market' imports of Monster Energy drinks. Monster Beverage Corporation filed a complaint on 17 April 2026, alleging that unauthorised foreign-market versions infringe its US trademarks due to differing packaging, ingredients, and labelling. The company is seeking a General Exclusion Order and cease-and-desist orders against multiple US and international respondents. This action, under Section 337 of the Tariff Act of 1930, seeks to block the importation and sale of these products, which Monster claims violate regulatory and trademark standards within the American market.
The investigation's unique aspect is its focus on genuine products intended for other markets being re-routed into the US without authorisation. If successful, this case could significantly impact how consumer packaged goods (CPG) companies leverage US trade law to protect intellectual property and market integrity. Experts suggest the outcome may have broad implications for trademark rights, regulatory compliance, and parallel imports across the entire CPG sector, not just beverages.
Separately, Monteloeder, owned by SuanNutra, has secured regulatory approval for its RelaxPLX sleep support ingredient in South Korea. The company, in collaboration with local partner COSMAX BIO, aims to expand its market presence in Asia-Pacific, targeting non-melatonin sleep support solutions. Data from Monteloeder indicates a growing consumer demand for clinically-backed ingredients specific to sleep quality rather than broad relaxation, catering to younger demographics and exploring innovative format options beyond traditional capsules.
In the innovation space, Israeli health-tech start-up MeNow is utilising AI to discover functional ingredients from waste streams, identifying potential disruptors for the GLP-1 sector. MeNow's algorithm scans 60,000 organisms and over 2 million natural molecules within its proprietary library to predict bioavailability, safety, and health benefits. The company's commercial model involves co-development, licensing, and joint go-to-market partnerships for novel, IP-protected ingredients, exemplified by a collaboration with Colgate that reportedly reduced development time for a gingivitis treatment by 75%.
What this means for United States
US brand owners, especially within the high-volume beverage and supplement sectors, must reassess their intellectual property protection strategies against parallel imports. A successful General Exclusion Order for Monster Energy could significantly reduce unauthorised grey-market product availability, potentially stabilising pricing and restoring brand control. Manufacturers and procurement leads should anticipate stricter import regulations and invest in supply chain traceability for their US-bound products. This precedent could empower brands to more aggressively combat parallel trade, impacting sourcing costs for raw materials or finished goods that might otherwise enter the US through unofficial channels, potentially increasing final product costs by 5-10% for affected brands.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.